Labcorp FY26 Q2 diluted EPS rises 28.5% to $3.64; revenue increases 5.8% to $3.73 billion

Reuters2026/07/30 10:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Labcorp Q2 2026 revenue rose 5.8% to USD 3.73 billion; diluted EPS climbed 28.5% to USD 3.64.
Operating income increased to USD 451.6 million, lifting operating margin 0.9 percentage point to 12.1%.
Diagnostics Laboratories revenue grew 5.5% to USD 2.9 billion; Biopharma Laboratory Services revenue increased 6.5% to USD 836.2 million.
Board lifted share repurchase authorization by USD 1 billion, leaving USD 1.4 billion remaining; quarterly dividend set at USD 0.72 per share.
Full-year 2026 guidance raised to revenue growth of 5.4% to 6.3% and adjusted EPS of USD 18.10 to USD 18.55.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607300650PR_NEWS_USPR_____DC15016) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Labcorp FY26 Q2 diluted EPS rises 28.5% to $3.64; revenue increases 5.8% to $3.73 billion

You may also like

Crypto prices